| |
| | [No title] (Site not responding. Last check: 2007-10-13) |
 | | In the above described embodiments of the invention, at least one single- chain antigen-binding polypeptide may have at least two tripeptide glycosylation sequences in tandem such that the Asn residues are separated by two amino acid residues and/or at least one set of two overlapping tripeptide glycosylation sequences such that the Asn residues are adjacent. |
 | | The above described methods may be facilitated with the glycosylated polypeptide or multivalent protein of the invention, which is conjugated to polyalkylene oxide which may also be conjugated to one or plurality of peptide, lipid, nucleic acid, drug, toxin, chelator, boron addend or detectable label molecule (s). |
 | | Proline residues flanking the tripeptide sequence in the +3 position are changed to alanines, as recommended by the compilation of Gavel, Y., and von Heijne, G., Protein Engng. |
| www.wipo.int /cgi-pct/guest/getbykey5?KEY=98/49198.981105&ELEMENT_SET=DECL (8187 words) |
|